skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good morning.

I would be interested in your thoughts about CTLT which was last addressed in Q&A in Dec 2019. It seems to be in a sweet space of the logistics and delivery of COVID-19 vaccines; it has contracts with JNJ and AZN; and Argus has a $100 price target on it. Worthwhile to purchase as a compliment to the big pharma companies themselves or are there better options in the same space?

As others have said, thank you for the amazing work 5i does!
Dave
Read Answer Asked by David C. on June 30, 2020
Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine
Read Answer Asked by Antoine on June 30, 2020
Q: ICad was added to the russel 2000 today yet dropped nearly 5%. Aren’t new additions to an index supposed to trigger a buy?
The company has been on a downtrend over last month. Any news to account for this? Do you still like? I understand it is very high risk.
Read Answer Asked by Karim on June 30, 2020
Q: I believe you have had favourable comments and outlook for both of these stocks in the past. In our current environment can you indicate your preference for a long term hold, and perhaps a brief discussion of any risks that go with the potential rewards?
Read Answer Asked by Stephen R. on June 29, 2020
Q: Hi team,
What are your thoughts on PTQ's latest prospectus offering? Does the amount of shares dilutive, and what metrics are used to calculate one warrant to purchase two shares at 1.60$ up to 12 months? Am looking at purchasing shares on weakness as it's prospects look promising due to the rising number of Covid 19 cases and the possibility of the company being bought out perhaps within the next 12 months.
Many thanks,
Jean
Read Answer Asked by Jean on June 29, 2020
Q: What is your opinion on this Canadian company which has just announced its IPO?
Read Answer Asked by Roy on June 29, 2020
Q: Do you have a number as to what the vaccine revenue might be for COVID 19 ?
It looks like perhaps 50 or more will be splitting the pie, yet a lot of money for all I think.
I am tracking NVAX, SRNE, MRNA.
All are up astronomically, but perhaps will double
Or more from here. Do you guys own any ?
Is there an ETF that holds these vaccine company’s?
Would you buy any, if so which one or one’s ?
I see SRNE is up 26% in the first 8 minutes this morning.
Thanks
Read Answer Asked by Luc on June 25, 2020
Q: Hi there,

Could I please get your 2 opinions on these US listed stocks? Would you consider them buys at the current prices? For NVTA can I get your opinion on their acquisition of ArcherDx?

Thanks for your great service!
Read Answer Asked by Michael on June 23, 2020
Q: I've been watching this one for a while, ever since you compared it favourably within the context of alternative energy / solar stocks. Wednesday's "dip" turns out to have been driven by a class action lawsuit concerning alleged revenue manipulations.

The press release from the legal firm filing the class action has this to say:

"On June 17, 2020, Prescience Point Capital Management issued a report alleging, among other things, that 'at least 39%, or $205.3 million, of [Enphase's] reported U.S. revenue is fabricated.' The report also claimed, citing former employees, that 'a large portion of [the Company's] astronomical growth over the past two years is attributable to accounting gimmicks that artificially inflate revenue and profits.'"

What are your thoughts on Enphase in light of this news?

Also, I'm curious given your experience, are you able to share any insights on how class action lawsuits affect companies and their share performance -- at least, until the allegations are actually proven or rejected in court?

Please deduct as needed.

Kind regards
Read Answer Asked by Marc on June 22, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!